. | . |
New chinks emerge in malaria's armour Paris (AFP) Feb 3, 2010 Investigators said on Wednesday they had made important lab discoveries in mosquitoes and the parasite which causes malaria, opening up new paths for attacking a disease that claims nearly a million lives per year. In one of two studies published in the British journal Nature, Yale University researchers said they had found more than two dozen smell receptors in the mosquito Anopheles gambiae that enables the insect to home in on human sweat. Some of the receptors "could be excellent targets" for chemicals to snare mosquitoes or repel them, said the study's senior author, John Carlson, a professor of molecular biology. "We're now screening for compounds that interact with these receptors," Carlson said in a press release. "Compounds that jam these receptors could impair the ability of mosquitoes to find us. Compounds that excite some of these receptors could help lure mosquitoes into traps or repel them. The best lures or repellents may be cocktails of multiple compounds." Malaria is transmitted when a female Anopheles mosquito takes a blood meal from a person infected with the disease and then hands on a parasite in its saliva when it bites someone else. The parasites hole up in the liver for a number of weeks and then break out, escaping into the bloodstream, where they infect red blood cells and mature and multiply. They erupt from the blood cells in waves, causing bouts of fever that can lead to coma or death. In the second study, scientists in Australia identified a mechanism that helps Plasmodium falciparum, the most lethal of the five malarial parasites, to infiltrate blood cells and evade the body's defenses. The parasite dispatches hundreds of so-called "effector" proteins into the blood cell's cytoplasm, modifying the cell and masking the invader from the immune system. One of the primers for this is an enzyme called Plasmepsin V. "Plasmepsin V is responsible for determining that all the hundreds of effector proteins are exported. If we could find drugs to block Plasmepsin V, the malaria parasite would die," said Alan Cowman of the Walter and Liza Hall Institute in Melbourne. There were 247 million cases of malaria in 2006, causing nearly one million deaths, according to the World Health Organisation (WHO) website. Most of the fatalities were African children. Countries that have widespread incidence of malaria are also hit economically, losing as much as 1.3 percent of their gross domestic product (GDP), says the WHO.
Share This Article With Planet Earth
Related Links Epidemics on Earth - Bird Flu, HIV/AIDS, Ebola
Safety risk associated with HIV drug Washington (UPI) Feb 1, 2009 The U.S. Food and Drug Administration says a rare but serious liver disorder has been reported in some HIV patients taking Videx/Videx EC. The FDA said Videx (didanosine) is an antiretroviral medicine first approved in 1991, while Videx EC is a delayed-release version of Videx. Videx/Videx EC is used in combination with other antiretroviral medicines to treat human immunodeficiency viru ... read more |
|
The content herein, unless otherwise known to be public domain, are Copyright 1995-2010 - SpaceDaily. AFP and UPI Wire Stories are copyright Agence France-Presse and United Press International. ESA Portal Reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. Advertising does not imply endorsement,agreement or approval of any opinions, statements or information provided by SpaceDaily on any Web page published or hosted by SpaceDaily. Privacy Statement |